跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Thyrofix - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Thyrofix
Approved
STANDARD
Thyrofix
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d37e04c0ee524c1e
Company
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories SA
Type
Standard
Approval Details
Approval Id
d37e04c0ee524c1e
Drug Approval Philippines Name
Thyrofix
Product Name
Thyrofix
Registration Number
DRP-14261
Brand Name
Thyrofix
Generic Name
Levothyroxine Sodium (as hydrate)
Dosage Form
Tablet
Dosage Strength
25 mcg
Manufacturer
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories SA
Importer
Ambicare Pharmaceuticals Inc.
Distributor
Ambicare Pharmaceuticals Inc.
Company Detail Path
/organization/uni-pharma-kleon-tsetis-pharmaceutical-laboratories-sa
Issuance Date
04 August 2023
Expiry Date
04 August 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d37e04c0ee524c1e
Type
Standard
Back to Philippines FDA Approvals